TITLE

ENTERITE E CISTITE - UMA CAUSA DE DOR ABDOMINAL NO LÚPUS

AUTHOR(S)
Marques, M. Raquel; Matos, Catarina; Oliveira, Susana
PUB. DATE
April 2009
SOURCE
Acta Reumatológica Portuguesa;2009, Vol. 34 Issue 2, p241
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We present a case of a 28-year-old black female patient with a previous diagnosis of overlapping syndrome of lupus and rheumatoid arthritis, treated with corticosteroids and methotrexate, who was admitted to our department due to abdominal pain with vomits and diarrhea for 15 days. On complementary evaluation elevated C-reactive protein and erythrocyte sedimentation rate, lactate dehydrogenase and amylase levels were detected, C3 was reduced, blood, faeces, peritoneal fluid and urine cultures were negative; abdominal computerized tomography disclosed jejunal thickening with parietal edema, bilateral ureterohydronephrosis and bladder parietal thickening; on endoscopy with biopsy there was chronic pangastritis and duodenitis; cystoscopy with biopsy showed chronic cystitis. Those aspects suggested lupus enteritis and cystitis which appear rarely associated and have poor prognosis. This patient was treated with high dose corticosteroids followed by azathioprine and prednisolone, with clinical and imaging improvement.
ACCESSION #
42430652

 

Related Articles

  • Bladder Complications in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus or Rheumatoid Arthritis. Plotz, Paul H.; Klippel, John H.; Decker, John L.; Grauman, Dan; Wolff, Bernard; Brown, B.C.; Rutt, George // Annals of Internal Medicine;Aug79, Vol. 91 Issue 2, p221 

    Presents a study which reviewed the bladder complications of several patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Methodology; Results; Discussion.

  • Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital. Lian, T-Y; Edwards, CJ; Chan, S-P; Chng, H-H // Lupus;2003, Vol. 12 Issue 8, p612 

    Patients with systemic lupus erythematosus (SLE) frequently have gastrointestinal (GI) symptoms. These are usually self-limiting and related to treatment side-effects or concurrent illness. However, abdominal pain may be due to bowel ischaemia which can lead to infarction and perforation. The...

  • Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature. Ishikawa, Yuki; Yukawa, Naoichiro; Ohmura, Koichiro; Hosono, Yuji; Imura, Yoshitaka; Kawabata, Daisuke; Nojima, Takaki; Fujii, Takao; Usui, Takashi; Mimori, Tsuneyo // Clinical Rheumatology;May2010, Vol. 29 Issue 5, p563 

    Antitumor necrosis factor (TNF) therapy has been associated with adverse immunologic events including systemic lupus erythematosus. However, the development of polymyositis (PM)/dermatomyositis (DM) associated with anti-TNF therapy is extremely rare. We experienced a case of a 48-year-old female...

  • Etanercept.  // Reactions Weekly;12/2/2006, Issue 1130, p15 

    The article presents the case of a 55-year-old woman who developed systemic lupus erythematosus during treatment with etanercept for rheumatoid arthritis. She experienced severe fatigue and malaise, intermittent high fever, muscle pain, gum bleeding and oral ulcers after several months of...

  • antirheumatic drugs. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p59 

    An encyclopedia entry for "antirheumatic drugs" is presented. They refer to a group of drugs used for the treatment of rheumatoid arthritis and types of arthritis that are caused by other autoimmune disorders such as systemic lupus erythematosus. Most commonly used antirheumatics include...

  • Methotrexate in systemic lupus erythematosus. Wong, J.M.; Esdaile, J.M. // Lupus;2005, Vol. 14 Issue 2, p101 

    The most appropriate treatment of moderate, nonorgan threatening disease activity in systemic lupus erythematosus (SLE) remains poorly defined, although methotrexate (MTX) is commonly used. The results of 20 uncontrolled case series and a single retrospective cohort study tend to support its use...

  • Case Study: Turmeric and NSAID withdrawal. Moppe, Jill // Medical Herbalism: A Journal for the Clinical Practitioner;Fall2000, Vol. 11 Issue 4, p6 

    The article presents the case study of a female diagnosed with systemic lupus erythematosus. She suffers from chronic joint inflammation and pain, especially in knees, elbows and hands. She was recommended to take medications including corticosteroids, methotrexate and lansoprazole. She...

  • Interstitial cystitis and systemic lupus erythematosus in a 20-year-old woman. do Socorro Teixeira Moreira Almeida, Maria; Carvalho, Luciano; Carvalho, Amanda; Almeida, João; Borges e Silva, Jeany // Rheumatology International;Dec2008, Vol. 29 Issue 2, p219 

    A 20-year-old woman with systemic lupus erythematosus presented with dysuria, urinary frequency and suprapubic pain and was found to have a chronic interstitial cystitis, a chronic inflammation of the bladder wall, mostly affecting middle-aged women. Chronic interstitial cystitis is an uncommon...

  • Subacute abdominal pain requiring hospitalization in a systemic lupus erythematosus patient: a retrospective analysis and review of the literature. Buck, A. C.; Serebro, L. H.; Quinet, R. J. // Lupus;Jul2001, Vol. 10 Issue 7, p491 

    In the systemic lupus erythematosus (SLE) patient, abdominal pain is a common problem. Intra-abdominal vasculitis must be excluded as the source because of its potentially high mortality rate. We retrospectively reviewed the charts of 56 SLE patients with 75 admissions for predominantly subacute...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics